Relief

Relief is Available

For moderate and severe Evaporative Dry Eye sufferers, life can seem like a constant struggle to temporarily alleviate symptoms and an ongoing struggle to accommodate life-altering inconveniences.

Warm compresses become a regular ritual, sometimes several times a day. A bottle of some form of eye drops is never far out of reach. Blinking exercises might be on the agenda, or maybe lid scrubs.

Contact lenses can only be worn for a limited time, if at all. Extended sessions in front of a computer are off limits. Relaxing with a good book may be too painful to contemplate. Even just deciding on the spur of the moment to go outside and enjoy a nice spring day could be out of the question.

Does any of this sound familiar?

If so, you need to know about the LipiFlow system, a technological breakthrough that has been developed to potentially make the discomfort, inconvenience and limitations of Evaporative Dry Eye a thing of the past.

Cost of Dry Eye in the US

The first study to measure the cost of dry eye disease in the U.S. indicates that the economic burden of dry eye is significant – $3.84 billion in direct health care costs each year. When the indirect costs of lost productivity are included, the societal burden of dry eye rises to $55.4 billion annually.

The average annual direct cost per patient ranges from $678 for patients with mild dry eye to $1,267 for severe cases. If pharmaceuticals and punctual plugs are used the costs rise to $2,959+ per year.

Mild and moderate dry eye sufferers incurred a productivity loss valued at more than $12,000 annually, while severe dry eye patients lost about $18,000 in workplace productivity. The vast majority of lost productivity was due not to missed days of work, but to impairment or reduced productivity at work.¹²